Active R&D Phase
BeatioPulse™ is currently in active R&D. We are actively seeking mission-aligned investors to fund this noble project and secure global patent protection.
Investor Diligence →
BeatioPulse Cardio Neural Intelligence
Class II Medical Device Clearance Pathway

Clearance Strategy, Predicate Benchmarks & Clinical Equivalence.

BeatioPulse combines proven 510(k) predicate device safety with transformative on-skin edge neural network intelligence. Review our predicate mappings, international medical standards, and 150-patient clinical protocol.

What is the BeatioPulse FDA 510(k) Clearance Pathway?

The BeatioPulse™ FDA 510(k) pathway is a Class II medical device submission under 21 CFR 870.2800 (product code MWI). It establishes substantial equivalence against predicate devices (iRhythm Zio and BioIntelliSense BioButton) through bench testing and a 150-patient multi-center IRB equivalence trial adhering to IEC 60601-1, IEC 62304, and ISO 13485:2016.

Substantial Equivalence

FDA 510(k) Predicate Device Comparative Analysis

Direct technical mapping against cleared commercial predicates.

Regulatory Parameter BeatioPulse™ AI Smart Patch Predicate 1: iRhythm Zio Patch (K121319) Predicate 2: BioIntelliSense BioButton (K201416)
Classification & Regulation Class II, 21 CFR 870.2800 Class II, 21 CFR 870.2800 Class II, 21 CFR 870.2910
Product Code MWI, DQA MWI DQA, DRG
Telemetry Modality Real-Time Sub-800ms Cloud Relay Post-monitoring postal mail-in (no real-time) Periodic BLE sync to cellular hub
Defibrillation Proofing 2,000V (IEC 60601-1 Type CF) Not defibrillator-proof Not rated for defibrillation
On-Device Machine Learning INT8 Neural Network on Nordic nRF5340 None (Server-side cloud processing only) Heuristic trend detection
Continuous Wear Duration 14 Days Continuous (IP68) 14 Days Continuous (Water-resistant) 16–30 Days (Continuous)
Patient Contact Materials Medical LSR Silicone (ISO 10993) Medical Adhesive Tape Medical Grade Silicone & Adhesive
Medical Standards

Regulatory Harmonization & Quality Systems

Conforming to the rigorous standards required by the FDA, European MDR, and international bodies.

01

IEC 60601-1

Electrical Safety

Type CF applied parts compliance with 2,000V defibrillation protection. Proprietary PCBA dielectric isolation barrier protects patient and clinician during emergency resuscitation.

02

IEC 62304 Class B

Software Lifecycle

Rigorous software architecture, static code verification, unit test tracing, and cybersecurity hazard mitigation (FDA Post-Market Cyber Guidance).

03

ISO 13485:2016

Quality Systems

Cleanroom manufacturing protocols, incoming component verification (AQL 0.65 Level II), pneumatic bed-of-nails ATE testing, and complete Device Master Records.

04

ISO 10993-5 & 10

Biocompatibility

Independent laboratory testing proving zero cytotoxicity, zero dermal irritation, and zero delayed-type hypersensitivity across 14-day continuous human wear.

Clinical Validation

150-Patient Multi-Center IRB Equivalence Protocol

Structured clinical trial designed to deliver statistically overwhelming proof of substantial equivalence.

Patient Cohort & Sites

150 enrolled adult cardiology patients across 3 independent academic medical centers. Cohort includes patients with paroxysmal AFib, PVC burden >5%, and post-ablation surveillance.

Primary Endpoints

Non-inferiority demonstrated against simultaneous 12-lead reference Holter recordings: QRS beat detection sensitivity ≥99.0%, positive predictivity ≥99.2%, and AFib episode sensitivity ≥98.5%.

Independent Adjudication

All conflicting arrhythmia classifications adjudicated by a 3-member blinded Clinical Events Committee (CEC) of board-certified clinical electrophysiologists.

Regulatory FAQ

Frequently Asked 510(k) Questions

What FDA regulatory classification applies to BeatioPulse?

BeatioPulse is categorized as a Class II medical device under 21 CFR 870.2800 (Medical magnetic tape recorder / ambulatory electrocardiograph), product code MWI and DQA.

What predicate devices are selected for the 510(k) submission?

The primary predicate devices are the iRhythm Zio Patch (K121319) and the BioIntelliSense BioButton (K201416), demonstrating substantial equivalence in patient contact materials, ECG lead sensitivity, and clinical indications for use.

What medical safety standards does the patch adhere to?

The patch is engineered to IEC 60601-1 (medical electrical safety and 2,000V defibrillation protection), IEC 60601-1-2 (EMC), IEC 62304 Class B (software lifecycle), ISO 10993 (biocompatibility), and ISO 13485:2016 (quality management).

Review Our Full Regulatory Binder

Accredited institutional investors and clinical research partners can request our complete 510(k) pre-submission documentation and DMR binder.

Explore Investor Diligence →